Welcome to the Abel Lab!

Care Delivery Research for Patients with Blood Cancers

The Abel Lab at Dana-Farber Cancer Institute applies health services research methods to understand the experiences of patients with blood cancers and develop interventions to improve care.

We are interested in evaluating how cancer and its therapies affect outcomes such as function and quality of life. Through our work and collaboration with researchers in oncology, hematology, geriatrics, ethics, and energy balance, we aim to ameliorate the impact of hematologic malignancies and their treatment from diagnosis to the end of life.

Dr. Abel discusses the care delivery and bioethics impact of telemedicine implementation at Dana-Farber with Dr. Wagner, the Medical Director of Adult Ambulatory Oncology.

Explore this website to learn about the Abel Lab’s current research and former projects.

Lab News — June 2026

Virgil Guo's analysis of patient-perceived caregiver burden after stem cell transplantation was presented during a poster session at the 2026 ASCO annual meeting.
Dr. Eric Blackstone, a bioethics research fellow with the Abel Lab, was awarded a K99/R00 to study the ethics of multi-cancer early detection testing.
Dr. Marron and Dr. Abel's article, "How I approach clinical ethics consultation in hematology," was published in Blood.